JPRN-UMIN000014851已完成未知
Retrospective clinical study of gynecology Cancer Immuno-Cell Therapy study group - Retrospective clinical study of gynecology Cancer Immuno-Cell Therapy study group
Juntendo University Hospital Department of Obstetrics and Gynecology0 个研究点目标入组 200 人开始时间: 2014年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The study of an evaluation for gynecological tumorovarian cancer, cervical cancer, uterine coorpus cancer, other gynecological malignanciesJPRN-UMIN000003341Department of Obstetrics and Gynecology,Osaka University Graduate School of Medicine200
招募中
不适用
Health Services Evaluation Pilot: Promoting an improved patient experience in gynaecological cancer care through supportive care screening and intervention.Gynaecological cancerMental healthCancer - Ovarian and primary peritonealCancer - Cervical (cervix)Mental Health - Studies of normal psychology, cognitive function and behaviourACTRN12615000428561niversity of Melbourne130
进行中（未招募）
不适用
Estudio aleatorizado del Gynaecologic Cancer InterGroup”, de dos grupos, multicéntrico para añadir bevacizumab a la quimioterapia estándar (carboplatino y paclitaxel) en pacientes que sufren cáncer epitelial de ovario - Bevacizumab en Cáncer de OvarioCarcinoma epitelial de ovario, carcinoma peritoneal primario o carcinoma de Trompas de Falopio. Neoplasma maligno de ovario.MedDRA version: 9.1Level: LLTClassification code 10026310Term: Malignant neoplasm of ovaryEUCTR2005-003929-22-ESGRUPO ESPAÑOL DE INVESTIGACIÓN EN CANCER DE OVARIO (GEICO)1,520
已完成
不适用
Efficacy of screening for gynecologic malignancies by measuring urine-blood porphyrin concentration using oral 5-aminolevulinic acidmalignant genital tumors benign gynecologic tumorsJPRN-UMIN000008890agoya University120
进行中（未招募）
不适用
A clinical registry for longitudinal data on the clinical, psychosocial, and economic impact of lung cancer treatment in ItalyCancerISRCTN67197140niversity of L'Aquila1,000